Press release
[Latest Research] GMP Cell Banking Service Market is expected to cross US$ 200 Mn Bn by 2025
The healthcare vertical is growing at a rapid pace all over. There are hordes of healthcare opportunities available. Digitization is making a constructive entry into the vertical. Plus, with an influx of AI technology, profound diagnostics of the diseases are being made possible. There is customized medical software to execute this. As such, the GMP cell banking services market is bound to climb the digitized pedestal in the years to come.North America is estimated to hold a whopping 45.3% value share in the global GMP cell banking services market by the end of 2017 and will witness an increase of 231 basis points in market share by 2025 over 2017. The North America regional market will create absolute $ opportunity of US$ 23 Mn in 2018 over 2017. In a new report titled "GMP Cell Banking Services Market: Global Industry Analysis and Forecast, 2017-2025," Persistence Market Research forecasts revenue from the North America market to grow 3.1x by 2025 end as compared to that in 2017.
๐๐๐๐๐ฌ๐ฌ ๐ ๐ซ๐๐ ๐๐๐ฆ๐ฉ๐ฅ๐ ๐๐จ๐ฉ๐ฒ ๐๐ ๐๐๐ ๐๐๐ฅ๐ฅ ๐๐๐ง๐ค๐ข๐ง๐ ๐๐๐ซ๐ฏ๐ข๐๐ ๐๐๐ซ๐ค๐๐ญ ๐๐๐ฉ๐จ๐ซ๐ญ@ https://www.persistencemarketresearch.com/samples/13735
๐๐จ๐ฆ๐ฉ๐๐ง๐ฒ ๐๐ซ๐จ๐๐ข๐ฅ๐๐ฌ:
WuXi AppTec
Charles River Laboratories International, Inc.
Eurofins Scientific
Merck KGaA
Lonza Group Ltd
SGS Ltd
ViruSure GmbH
Austrianova
Goodwin Biotechnology Inc.
Paragon Bioservices, Inc.
๐๐ญ๐ซ๐๐ญ๐๐ ๐ข๐ ๐ข๐ง๐๐ฎ๐ฌ๐ญ๐ซ๐ฒ ๐๐จ๐ง๐ฌ๐จ๐ฅ๐ข๐๐๐ญ๐ข๐จ๐ง๐ฌ ๐๐ง๐ ๐ข๐ง๐๐ซ๐๐๐ฌ๐ ๐ข๐ง ๐๐๐ฆ๐๐ง๐ ๐๐จ๐ซ ๐๐๐๐๐ฒ-๐ญ๐จ-๐๐ฌ๐ (๐๐๐) ๐๐ข๐จ๐๐ฌ๐ฌ๐๐ฒ ๐๐๐ง๐ค๐ฌ ๐ข๐ฌ ๐ญ๐ซ๐๐ง๐๐ข๐ง๐ ๐ญ๐ก๐ ๐ ๐ฅ๐จ๐๐๐ฅ ๐๐๐ ๐๐๐ฅ๐ฅ ๐๐๐ง๐ค๐ข๐ง๐ ๐ฌ๐๐ซ๐ฏ๐ข๐๐๐ฌ ๐ฆ๐๐ซ๐ค๐๐ญ
One of the key objectives of the report is to identify the key trends governing the global GMP cell banking services market and present a clear picture of the various forces impacting the market at a micro and macro level. A sustained growth of the market can be attributed to macro-economic drivers such as increased public and private sector funding for disease research, which is expected to bring newer therapies to the market; high costs of clinical development; and various collaborative initiatives to identify therapies for difficult-to-treat illnesses.
On the supply side, an expansion of production facilities by key players to meet growing customer demand besides offering customized solutions based on specific customer needs (this involves strategic tie-ups between biopharmaceutical companies and cell banking service providers) are some of the factors likely to push the global GMP cell banking services market ahead in the coming years. The report also identifies certain demand side drivers boosting the market such as a growing number of biologics in development currently, limited in-house storage and testing capabilities and a rise in the demand for outsourcing and contract manufacturing.
While the above growth factors are indicative of a mature market, Persistence Market Research identifies certain pull factors likely to restrain the market to a certain extent in the coming years. First off, the global GMP cell banking services market is highly fragmented with multiple vendors offering a variety of services - resulting in limited global reach. Besides, complexities in the production and manufacturing processes, a constantly evolving technology landscape, and inconsistent demand for services are likely to restrain revenue growth of the global GMP cell banking services market during the forecast period.
๐๐๐ช๐ฎ๐๐ฌ๐ญ ๐ ๐จ๐ซ ๐๐๐ฉ๐จ๐ซ๐ญ ๐๐ฎ๐ฌ๐ญ๐จ๐ฆ๐ข๐ณ๐๐ญ๐ข๐จ๐ง -https://www.persistencemarketresearch.com/request-customization/13735
Persistence Market Research predicts a large opportunity for key players in the fast growing Asia Pacific region. It must be noted that there has been a shift of R&D and technology investments in the healthcare industry from North America and Europe to Asia Pacific with developing APAC economies such as India offering increased scope for outsourcing of biotech projects owing to ample skilled and qualified manpower at optimal costs.
๐๐๐ฆ๐ฆ๐๐ฅ๐ข๐๐ง ๐๐๐ฅ๐ฅ ๐ญ๐ฒ๐ฉ๐ ๐ฌ๐๐ ๐ฆ๐๐ง๐ญ ๐ญ๐จ ๐ซ๐๐ญ๐๐ข๐ง ๐ข๐ญ๐ฌ ๐ฉ๐จ๐ฅ๐ ๐ฉ๐จ๐ฌ๐ข๐ญ๐ข๐จ๐ง ๐ญ๐ก๐ซ๐จ๐ฎ๐ ๐ก๐จ๐ฎ๐ญ ๐ญ๐ก๐ ๐๐จ๐ซ๐๐๐๐ฌ๐ญ ๐ฉ๐๐ซ๐ข๐จ๐
Among the cell type segments, the Mammalian segment was the dominant segment in 2016 and is expected to retain its dominance through 2025. From an estimated US$ 216 Mn in 2017 to a market excess of US$ 680 Mn by the end of the forecast period, the Mammalian segment will register the highest CAGR of 15.6% among the other cell type segments. The Microbial segment is the second most attractive cell type segment in the global GMP cell banking services market in terms of revenue. Registering a value CAGR of 12.9% between 2017 and 2025, the Microbial segment will hold the second position among the cell type segments of the global GMP cell banking services market.
๐๐ข๐จ๐ฉ๐ก๐๐ซ๐ฆ๐๐๐๐ฎ๐ญ๐ข๐๐๐ฅ ๐๐จ๐ฆ๐ฉ๐๐ง๐ข๐๐ฌ ๐ฐ๐ข๐ฅ๐ฅ ๐๐ ๐ญ๐ก๐ ๐ฅ๐๐ซ๐ ๐๐ฌ๐ญ ๐๐ง๐ ๐ฎ๐ฌ๐๐ซ๐ฌ ๐จ๐ ๐๐๐ ๐๐๐ฅ๐ฅ ๐๐๐ง๐ค๐ข๐ง๐ ๐ฌ๐๐ซ๐ฏ๐ข๐๐๐ฌ
Among the end user segment of the global GMP cell banking services market, the Biopharmaceutical Companies segment will emerge the undisputed leader both in terms of market share (estimated to hold almost 69% share by 2017 end) and CAGR (an impressive 15.4% during 2017 - 2025). In comparison, the Contract Manufacturing Organizations segment will come a pale second, recording a market attractiveness index of 0.5 during the forecast period.
๐๐จ ๐๐จ "๐๐ฎ๐ซ๐๐ก๐๐ฌ๐ ๐๐จ๐ฐ" ๐๐จ ๐๐๐ฏ๐ ๐๐ฎ๐ซ ๐๐๐ ๐๐๐ฅ๐ฅ ๐๐๐ง๐ค๐ข๐ง๐ ๐๐๐ซ๐ฏ๐ข๐๐ ๐๐๐ซ๐ค๐๐ญ ๐๐๐ฉ๐จ๐ซ๐ญ@ https://www.persistencemarketresearch.com/checkout/13735
๐๐๐ฒ ๐๐ฎ๐๐ฌ๐ญ๐ข๐จ๐ง๐ฌ ๐๐ง๐ฌ๐ฐ๐๐ซ๐๐ ๐ข๐ง ๐๐ก๐ข๐ฌ ๐๐๐ฉ๐จ๐ซ๐ญ.
What are the Roadblocks for GMP Cell Banking Services Suppliers?
What are the Key Opportunities for GMP Cell Banking Services Manufacturers?
How is Focus on Safety Influencing GMP Cell Banking Services Demand?
What is the Regulatory Impact on Global Sales of GMP Cell Banking Services?
Which Region Offers the Largest Opportunity for Sales of GMP Cell Banking Services?
Where Does the U.S. Stand in the Market for GMP Cell Banking Services?
What Is the Outlook for GMP Cell Banking Services Manufacturers in China?
Why is Germany a Lucrative Market for GMP Cell Banking Services Manufacturers?
Why Will Belgium Outpace Other European Markets for GMP Cell Banking Services?
Why is There High Demand for Tires in GMP Cell Banking Services?
Why are Sales of Tubeless GMP Cell Banking Services Surging?
๐๐๐จ๐ฎ๐ญ ๐๐๐ซ๐ฌ๐ข๐ฌ๐ญ๐๐ง๐๐ ๐๐๐ซ๐ค๐๐ญ ๐๐๐ฌ๐๐๐ซ๐๐ก:
Business intelligence is the foundation of every business model employed by Persistence Market Research. Multi-dimensional sources are being put to work, which include big data, customer experience analytics, and real-time data collection. Thus, working on "micros" by Persistence Market Research helps companies overcome their "macro" business challenges.
Persistence Market Research is always way ahead of its time. In other words, it tables market solutions by stepping into the companies'/clients' shoes much before they themselves have a sneak pick into the market. The pro-active approach followed by experts at Persistence Market Research helps companies/clients lay their hands on techno-commercial insights beforehand, so that the subsequent course of action could be simplified on their part.
๐๐จ๐ง๐ญ๐๐๐ญ
Rajendra Singh
Persistence Market Research
U.S. Sales Office:
305 Broadway, 7th Floor
New York City, NY 10007
+1-646-568-7751
United States
USA - Canada Toll-Free: 800-961-0353
Email: sales@persistencemarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release [Latest Research] GMP Cell Banking Service Market is expected to cross US$ 200 Mn Bn by 2025 here
News-ID: 3245402 • Views: โฆ
More Releases from Persistence Market Research

Plastic Liner Market to Reach US$ 6.67 Bn by 2030, Expanding at 4.7% CAGR - Pers โฆ
โค Overview of the Market
The global plastic liner market has gained steady traction across multiple industries due to its cost-effectiveness, versatility, and protective characteristics. Plastic liners are widely used in agriculture, mining, construction, waste management, and packaging industries, where they serve as an essential barrier to prevent leakage, contamination, and material loss. These liners are manufactured using materials such as polyethylene (PE), polypropylene (PP), and PVC, offering superior resistance toโฆ

Returnable Plastic Crate Market to Reach US$ 2,665.1 Million by 2030 Fueled by S โฆ
โค Overview of the Market
The global returnable plastic crate market is gaining momentum as industries seek cost-effective and sustainable packaging solutions. These crates are widely used for transporting and storing perishable goods, beverages, pharmaceuticals, and industrial products due to their durability, stackability, and reusability. The shift from single-use packaging to eco-friendly alternatives has accelerated the adoption of returnable plastic crates across sectors. The market, valued at US$ 1,820.0 million inโฆ

US Thermal Power Market Expected to Reach US$ 251.9 Mn by 2031 with 2.4% CAGR Gr โฆ
โคOverview of the Market
The US thermal power market plays a crucial role in the nation's energy mix, serving as a stable and reliable source of electricity despite the rise of renewables. Thermal power plants in the US rely primarily on coal, natural gas, and oil to generate electricity, with natural gas emerging as the dominant fuel source due to its affordability, efficiency, and lower carbon footprint compared to coal. Accordingโฆ

Europe Medical Plastic Market to Reach US$ 17 Bn by 2032 Driven by Rising Health โฆ
โคOverview of the Market
The Europe medical plastic market is undergoing robust growth, fueled by increasing demand for lightweight, durable, and cost-effective materials in the healthcare sector. Medical plastics are widely used in devices, surgical instruments, diagnostic tools, implants, and packaging due to their high biocompatibility, versatility, and resistance to sterilization methods. With healthcare systems across Europe investing heavily in modernization and patient safety, the adoption of medical-grade plastics has gainedโฆ
More Releases for GMP
Creative Peptides Released GMP Synthesis Service
Located in Shirley, New York, the worldโs leading peptide supplier Creative Peptides announced the launch of its GMP synthesis (https://www.creative-peptides.com/services/custom-gmp-peptide-synthesis-services.html ) business on August 29, 2018. Now this company is focused on the development and GMP manufacturing of pharmaceutical grade peptides.
As the demand of pharmaceutical market continues to grow, more and more pharmas and research institutions choose the CMO and CRO models to expand their businesses, which is moreโฆ
Diapharm implements European GMP guidelines in China
Mรผnster (DE), London (UK), Ningbo (CN), 20 December 2013 โ Pharmaceutical service provider Diapharm (diapharm.com) is increasing its business activities in China: Diapharm has now implemented a โEuropeanโ quality management system for Neptune Pharma Ltd (www.neptunepharma.com) in their Joint Venture Partnerโs factory in Ningbo, Zhejiang Province. And it has done so successfully: The veterinary medicinal product Trident 500mg/g Powder for Suspension for Fish Treatment (www.trident-50.com), is manufactured onsite under EUโฆ
ECA Foundation releases free GMP WebApp
The ECA Foundation has been providing advanced training and information services in the pharmaceutical industry and especially with regard to pharmaceutical Quality Assurance and GMP compliance for more than 10 years. Now the organisation took advantage of its extensive experience to develop a further free of charge service โ the new GMP WebApp.
This new GMP WebApp runs on all smartphones and tablet PCs (Apple and Android platforms) and allows usersโฆ
GMP Friction Products Awarded ISO 9001:2008
Internationally Recognized Certification Measures Consistency in Process, Procedure and Quality Performance in Manufacture of Friction Materials
AKRON, OH (March 23, 2011) -- GMP Friction Products, a world leader manufacturing powdered metal friction products for clutch plates and brake pads, recently received certification for ISO 9001:2008.
โISO 9001:2008 signifies we have taken the extra measure of documenting the policies and standards to ensure consistent compliance with our manufacturing processes,โ said Jerry Lynch,โฆ
GMP MANUAL Volume 2 - Validation Procedures by Maas & Peither AG โ GMP Publish โฆ
GMP Publishing is launching its new GMP MANUAL Volume 2 โ Validation Procedures.
The compendium on validation procedures was written by Dr. Doris Borchert, Dr. Peter Bosshard, Dr. Ralph Gomez, Dr. Michael Hiob, Dr. Christine Oechslein, Max Lazar, Ulrike Reuter, Michael Schulte, Uwe Schwarzat โ all international experts and key opinion leaders. They share their detailed understanding of the various aspects of the validation process in clear and comprehensive styleโฆ
blue inspection body celebrates 50 GMP audits
Mรผnster (Germany), 20 November 2009. Two years after founding the company and just 18 months after gaining the accreditation blue inspection body GmbH announced today the successful execution of its 50th GMP audit. Further audit trips to China, India, Israel and various European countries have been scheduled already, meaning that in the first quarter 2010 the 75th audit is targeted to be completed. Blue, as a privately organised inspection body,โฆ